AI assistant
Sight Sciences, Inc. — Director's Dealing 2025
Dec 30, 2025
33763_dirs_2025-12-30_25327668-2c49-48d1-9ef6-548c99d9540e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Sight Sciences, Inc. (SGHT)
CIK: 0001531177
Period of Report: 2022-09-21
Reporting Person: Badawi David (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-09-21 | Stock Option (Right to Buy) | $0.23 | M | 40000 | Disposed | 2026-02-28 | Common Stock (40000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1448656 | Direct |
Footnotes
F1: Includes 1,441,196 shares that were previously reported as beneficially owned on the Reporting Person's Form 3 filed on July 14, 2021, as well as 7,460 shares that were acquired by the Reporting Person upon exercise of options prior to the Issuer's completion of the Initial Public Offering in July 2021 that should have been included under Column 2 of Table I of the Form 3 but were inadvertently included as shares underlying options with an exercise price of $0.23 that expire on February 28, 2026 under Column 3 of Table II of the Form 3.
F2: The grant of stock options ("Options") made to the Reporting Person vested and became exercisable as to 25% of the underlying shares on January 1, 2017, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on January 1, 2020.
F3: The original Form 4 filing identified the expiration date of the relevant Options as 01/08/2027. This amendment corrects the expiration date of the relevant Options to February 28, 2026.
F4: Excludes the 7,460 shares that were previously inadvertently included as described in footnote (1) to this Form 4.